Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

Published:2023-11 Issue:22 Volume:82 Page:2087-2096
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Butler Javed,Abildstrøm Steen Z.,Borlaug Barry A.,Davies Melanie J.,Kitzman Dalane W.,Petrie Mark C.,Shah Sanjiv J.,Verma Subodh,Abhayaratna Walter P.,Chopra Vijay,Ezekowitz Justin A.,Fu Michael,Ito Hiroshi,Lelonek Małgorzata,Núñez Julio,Perna Eduardo,Schou Morten,Senni Michele,van der Meer Peter,von Lewinski Dirk,Wolf Dennis,Altschul Rebecca L.,Rasmussen Søren,Kosiborod Mikhail N.

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Heart failure. A proposed definition and classification;Wagner;Arch Intern Med,1977

2. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

3. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;J Am Coll Cardiol,2022

4. Universal Definition and Classification of Heart Failure

5. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial;Yusuf;Lancet,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life;Cardiac Failure Review;2024-09-11

2. Response by Kosiborod et al to Letter Regarding Article, “Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial”;Circulation;2024-09-03

3. Can Semaglutide offer hope for patients with obesity-related heart failure?;Current Problems in Cardiology;2024-09

4. Obesity and Weight Loss Strategies for Patients With Heart Failure;JACC: Heart Failure;2024-09

5. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Journal of Preventive Cardiology;2024-08-30